Bio-Medical Applications of Virginia, INC.
Bio-Medical Applications of Virginia, INC. was paid $4.44M by Medicaid between Jan 2018 and Dec 2024, across 48 billing codes. Its largest line is 90999, dialysis (unlisted procedure) — 87% of everything it billed.
NORFOLK, VA 23502
Next to other End-Stage Renal Disease (ESRD) Treatment Clinic/Center providers in Virginia
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 28,962 | $342K | |
| 2019 | 25,936 | $257K | |
| 2020 | 24,745 | $307K | |
| 2021 | 22,858 | $395K | |
| 2022 | 33,699 | $614K | |
| 2023 | 127,435 | $2.23M | |
| 2024incomplete | 13,191 | $295K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 90999 | Dialysis (unlisted procedure)Unlisted dialysis procedure, inpatient or outpatient | 87% | 40,892 | 3,963 | $3.86M |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 11% | 4,713 | 2,532 | $475K |
| 90935 | Hemodialysis procedure with single evaluation by a physician | 1.1% | 339 | 45 | $49K |
| J0606 | Injection, etelcalcetide, 0.1 mg | <1% | 2,867 | 231 | $35K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | <1% | 4,443 | 538 | $12K |
| A4657 | Syringe, with or without needle, each | <1% | 73,781 | 3,482 | $2K |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 8,702 | 1,853 | $1K |
| J1270 | Injection, doxercalciferol, 1 mcg | <1% | 27,367 | 2,361 | $659.39 |
| 84520 | <1% | 8,976 | 3,422 | $615.15 | |
| 85018 | <1% | 12,872 | 3,594 | $379.50 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 33,782 | 1,531 | $352.23 |
| 83550 | <1% | 3,769 | 3,221 | $349.44 |
36 more codes
| 84100 | <1% | 4,686 | $335.82 | |
| 82040 | <1% | 3,748 | $331.32 | |
| 83540 | <1% | 3,917 | $328.53 | |
| 82565 | <1% | 3,600 | $305.19 | |
| 82374 | <1% | 2,786 | $298.96 | |
| 85027 | <1% | 808 | $278.98 | |
| 84075 | <1% | 1,177 | $274.40 | |
| 83970 | <1% | 3,579 | $200.58 | |
| G0010 | Administration of hepatitis b vaccine | <1% | 106 | $135.58 |
| 90739 | <1% | 106 | $134.15 | |
| 82310 | <1% | 6,444 | $65.95 | |
| 84132 | <1% | 6,065 | $53.62 | |
| 82728 | <1% | 1,767 | $38.73 | |
| 84295 | <1% | 1,335 | $32.61 | |
| 87340 | <1% | 1,769 | $28.57 | |
| 86706 | <1% | 406 | $20.51 | |
| 86803 | <1% | 93 | $1.78 | |
| G0008 | Administration of influenza virus vaccine | <1% | 197 | $1.24 |
| 83735 | <1% | 689 | $1.16 | |
| 82947 | <1% | 320 | $0.70 | |
| 85046 | 0% | 346 | $0.00 | |
| A6216 | Gauze, non-impregnated, non-sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | 0% | 5,384 | $0.00 |
| 84155 | 0% | 886 | $0.00 | |
| 90682 | 0% | 81 | $0.00 | |
| 82108 | 0% | 143 | $0.00 | |
| 0124A | 0% | 12 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 38 | $0.00 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 1,083 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 129 | $0.00 |
| 90686 | 0% | 32 | $0.00 | |
| J3490 | Unclassified drugs | 0% | 1,232 | $0.00 |
| 80069 | 0% | 314 | $0.00 | |
| 80051 | 0% | 950 | $0.00 | |
| 86704 | 0% | 40 | $0.00 | |
| 90688 | 0% | 35 | $0.00 | |
| 82746 | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.